Results suggest tocilizumab and sarilumab improve outcomes for those with life-threatening infections
Two drugs used to treat rheumatoid arthritis could help to save the lives of intensive care patients with severe Covid, researchers have found.
Early results from the international trial previously suggested tocilizumab might improve outcomes for those with life-threatening coronavirus infections. However, other trials reported mixed results.
